Superose 6 Increase columns

Similar documents
High-throughput process development and scale-up of an intermediate purification step for recombinant insulin

Use of Capto ViralQ for the removal of genomic DNA from influenza virus produced in MDCK cells

Amersham ECL Prime Western blotting reagent

Sephadex G-25 media and prepacked formats

GE Healthcare Life Sciences. Quality matters. Whatman TM filters for air monitoring

BabyBio IMAC columns DATA SHEET DS

Sephadex G-25 resins and prepacked formats

Prepacked chromatography columns for ÄKTA systems

Concentration and diafiltration of cell-derived, live influenza virus using 750 C hollow fiber filter cartridge

Agilent Anion-Exchange Media for Proteins - Loading vs Resolution - Effect of Flow Rate and Example Protein Separations

Use of online cell counting for micronucleus and neurite outgrowth assays on IN Cell Analyzer 2000

Caution: For Laboratory Use. A product for research purposes only. Eu-W1284 Iodoacetamido Chelate & Europium Standard. Product Number: AD0014

LANCE Eu-W1024 ITC Chelate & Europium Standard AD0013 Development grade

Caution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard. Product Number: AD0013

Ion Exchange Chromatography COSMOGEL IEX Series Columns

DELFIA Tb-N1 DTA Chelate & Terbium Standard

DELFIA Tb-DTPA ITC Chelate & Terbium Standard

Data File. Sephadex ion exchange media. Ion exchange chromatography. Introduction. Sephadex ion exchangers General description

Europium Labeling Kit

DELFIA Eu-DTPA ITC Chelate & Europium Standard

TiO 2 Mag Sepharose. SepharoseTM. GE Healthcare. Simple handling

TSKgel Hydrophobic Interaction Chromatography Columns

Peptide sequencing using chemically assisted fragmentation (CAF) and Ettan MALDI-ToF Pro mass spectrometry

GE Healthcare Life Sciences. Methodology Guideline AA. Quantification of influenza hemagglutinin using Biacore T200

Supplementary material: Materials and suppliers

Insulin SEC analysis. Insulin Samples:

SeQuant ZIC -HILIC For all who expect more...

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

YMC-Actus. Columns for Semi-preparative HPLC. Selectivity Durability Loadability

Biacore biosensor assays for

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

SUPPLEMENTARY MATERIAL

Preparation of SG3249 antibody-drug conjugates

InertSustainBio C18. Rapid Separations of Proteins and Peptides

The Immunoassay Guide to Successful Mass Spectrometry. Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

ECL Plex Western Blotting Detection System

ACQUITY UPLC WITH PDA DETECTION: DETERMINING THE SENSITIVITY LIMITS OF OXYBUTYNIN AND RELATED COMPOUNDS

SeQuant ZIC -HILIC For all who expect more...

SMART Digest Kit Facilitating perfect digestion

Metal Chelate Affinity Chromatography

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

Tunable Hydrophobicity in DNA Micelles Anaya, Milena; Kwak, Minseok; Musser, Andrew J.; Muellen, Klaus; Herrmann, Andreas; Müllen, Klaus

vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15

Hydrophobic Interaction Chromatography

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

Mercury Speciation Determinations in Asian Dietary Supplements

A New HILIC/RP Mixed-Mode Column and Its Applications in Surfactant Analysis

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Normal Phase HPLC Column COSMOSIL SL-II

Exo-spin Exosome Purification Kit For cell culture media/urine/saliva and other low-protein biological fluids

Characterization of Starch Polysaccharides in Aqueous Systems: de facto molar masses vs supermolecular structures

Selection and Optimization of the Sample Introduction System

HPLC. Varian Dynamax Preparative HPLC Columns

STORE AT 4 o C Version 3

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

b-galactosidase Staining Kit

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

Impurity Profiling of Carbamazepine by HPLC/UV

Analytical and Preparative SFC Columns

Supplemental Figure 1 ELISA scheme to measure plasma total, mature and furin-cleaved

Purification of Glucagon3 Interleukin-2 Fusion Protein Derived from E. coli

Ovalbumin removal in egg-based influenza vaccine production using Capto Core 700

Mammalian Membrane Protein Extraction Kit

Babu Antharavally, Ryan Bomgarden, and John Rogers Thermo Fisher Scientific, Rockford, IL

World Journal of Pharmaceutical Research

His n. Vivapure Metal Chelate Mega spin columns. Technical data and operating instructions. For in vitro use only.

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

LC Columns - Exceed the limit. A premium inert range of LC columns delivering optimal peak shape. ProteCol -P PEEK lined

Manual. Precision Red Advanced Protein Assay Reagent. Cat. # ADV02. cytoskeleton.com. Cytoskeleton, Inc.

Supplementary Materials for

Structural Characterization of Prion-like Conformational Changes of the Neuronal Isoform of Aplysia CPEB

SUMMARY, CONCLUSION & RECOMMENDATIONS

INSTRUCTION MANUAL. RNA Clean & Concentrator -5 Catalog Nos. R1015 & R1016. Highlights. Contents

Size Exclusion Chromatography YMC-Pack Diol

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

A New Era in SFC Column Technology

For Research Use Only Ver

Pelagia Research Library

Choosing Preparative Columns

Propagation of influenza virus in Vero cells using Cytodex TM microcarriers in WAVE Bioreactor TM systems

PRODUCT INFORMATION & MANUAL

YMC-Triart C18. Multi-layer hybrid material for HPLC ph and temperature stability. Innovative micro-reactor technology

InertSustain Phenylhexyl. A New Second Choice Column to Change Chromatographic Behavior

For Research Use Only Ver

AMPK Assay. Require: Sigma (1L, $18.30) A4206 Aluminum foil

MagCapture Exosome Isolation Kit PS Q&A

TSKgel Size Exclusion Chromatography Columns

Stability indicating RP-HPLC method development and validation of Etizolam and Propranolol hydrochloride in pharmaceutical dosage form

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

USP Method Transfer of Ziprasidone HCl from HPLC to UPLC

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

Operating Instructions

Transcription:

Data file 9-99- AA Size-exclusion chromatography Superose Increase columns Superose Increase prepacked columns (Fig ) are designed for rapid separation and analysis of proteins and other biomolecules by size exclusion chromatography (SEC, also known as gel filtration), in the molecular weight (M r ) range for globular proteins between and. This very wide fractionation range of the chromatographic medium makes it suitable for purification of protein complexes, membrane proteins, and other macromolecules. The columns are also useful as a screening tool to explore the molecular-weight distribution of unknown samples. This new generation SEC medium replaces the well-known Superose columns. Superose Increase columns offer: Increased resolution compared with Superose, for higher purity and improved analysis results. Reduced runtime compared with Superose, for rapid results. Versatile use for both preparative and analytical applications, especially for large proteins and complexes. Tolerance to repeated harsh cleaning procedures at high ph, giving long column lifetime and minimal carry-over. Medium characteristics The chromatography medium in Superose Increase columns is based on a high-flow agarose base matrix with good pressure/flow properties and small bead size. The small beads of the medium allow high-resolution analytical separations. The low nonspecific interaction of the medium permits high recovery of biological materials. Further characteristics of the Superose Increase medium are shown in Table. Fig. Superose Increase./, Superose Increase / GL, and Superose Increase / GL prepacked columns are designed for high-resolution SEC of large proteins, protein complexes, and membrane proteins. Table. Main characteristics of Superose Increase medium Fractionation range M r to (globular proteins) M * p to (dextrans) Exclusion limit (M r ) Approx. 7 (globular proteins) ph stability to (long term) to (short term) Operating temperature ºC to ºC Storage temperature ºC to ºC Matrix Composite of cross-linked agarose Average bead size 8. μm * Peak molecular mass gelifesciences.com

Table. Characteristics of columns prepacked with Superose Increase Column Bed dimensions, diameter height (mm) Approximate bed volume (ml) Column efficiency (theoretical plates m - ) Recommended sample volume (µl) Recommended flow rate, H O at C (ml/min) Max. flow rate, H O at C (ml/min) Typical pressure drop over column, H O at C (MPa) Superose Increase / GL > 8 to... Superose Increase / GL > to..7. Superose Increase./.. > 8 to... Note: Flow rate needs to be decreased when working at low temperature or with viscous solutions, see product instructions for more details. Table. Column choice for different applications Type of application/column / GL / GL./ Small-scale preparative runs (mg) Microscale preparative runs (µg) When sample amount is limited and small consumption of buffer is important High-resolution analysis ( to µl) High-resolution analysis ( to µl) When sample amount is limited and small consumption of buffer is important Purity check Rapid screening When time is limited and small buffer and sample consumptions are important Selectivity of the medium Both Superdex Increase and Superose Increase belong to the new generation of SEC media based on high-flow agarose with small beads. They have different selectivity to complement each other. Figure shows that Superose Increase enables improved separation in the higher molecular weight range compared with Superdex Increase, both for proteins and dextrans. (A) Molecular weight (M r ) Proteins Superose Increase / GL column Superdex Increase / GL column 8 8 8 Elution volume (ml) (B) Dextrans 9 8 Superose Increase / GL column 7 Superdex Increase / GL column 8 8 Elution volume (ml) Fig. Selectivity of Superose Increase chromatography medium compared with Superdex Increase for a range of (A) proteins from M r down to M r and (B) dextrans from M p 8 down to M p. Molecular weight (M p ) Chemical stability Superose Increase medium is stable in aqueous solutions over the ph range to. Solutions containing chaotropic agents ( M guanidine hydrochloride, 8 M urea) and detergents such as SDS (up to %) can be used together with the medium without affecting its performance. Superose Increase medium also withstands the conditions used for cleaning-in-place (CIP) in the ph range to. Column characteristics and column selection Superose Increase is available prepacked in Tricorn high-performance glass columns of two different sizes (/ GL and / GL) as well as in the column format./ (Table ). All columns are made of glass to allow easier visual inspection of the packed bed. Each column has its own application purpose. Superose Increase / GL is designed for high-resolution preparative-scale purification (< µl sample volume), protein analysis, and protein characterization. Superose Increase./ column is an excellent choice when working with very small sample volumes ( to µl) and for high-resolution microscale separations using systems such as ÄKTAmicro. Superose Increase / GL is the first choice for rapid screening, for applications where buffer consumption needs to be low, and for purity checks. An overview of which column to choose for different applications is shown in Table. Fittings for simple connection to ÄKTA chromatography systems or equivalent high-performance systems are provided. All column parts are biocompatible. 9-99- AA

Improved resolution compared with Superose Superose Increase / GL column has higher resolution capabilities compared with the original Superose / GL column. Figure shows the result of the separation of standard proteins by SEC using Superose Increase / GL compared with Superose / GL. The sharper peaks observed on Superose Increase confirm higher resolution. The improved resolution can be attributed to the reduced bead size of Superose Increase medium (8. μm) compared with the larger beads of Superose ( μm). The higher rigidity of the chromatography beads and thereby enhanced flow properties enable rapid runs on Superose Increase. Columns: Superose Increase / GL and Superose / GL. Thyroglobulin (M r 9 ), mg/ml. Ferritin (M r ),. mg/ml. Aldolase (M r 8 ), mg/ml. Ovalbumin (M r ), mg/ml. Ribonuclease A (M r 7), mg/ml. Aprotinin (M r ), mg/ml Sample volume: µl Buffer: PBS ( mm phosphate buffer, mm NaCl, ph 7.) Flow rate:. ml/min ÄKTAmicro (A) Superose Increase / GL Superose Increase complements Superdex Increase The high resolution and wide fractionation range of Superose Increase columns allows for effective separation of protein aggregates. In Figure, purification of six model proteins on Superose Increase / GL revealed a broad peak corresponding to IgM. Using Superdex Increase / GL, this was not observed. It was later confirmed by light scattering that the IgM sample contained isoforms and aggregates. Columns: Superose Increase / GL and Superdex Increase / GL. IgM (M r ~97 )*,. mg/ml. Thyroglobulin (M r 9 ), mg/ml. Ferritin (M r ),. mg/ml. BSA (M r ), mg/ml. Myoglobin (M r 7 ),. mg/ml. Vitamin B (M r ),. mg/ml Sample volume: µl Buffer: PBS ( mm phosphate buffer, mm NaCl, ph 7.) Flow rate:. ml/min ÄKTAmicro * Sample also contained aggregated forms of IgM. (A) Superose Increase / GL 7.. A 8 8 A 8..... Aggregates...... Vol. (ml)...... Vol. (ml) (B) Superose / GL (B) Superdex Increase / GL 7. + aggregates. A 8 8 A 8.......... Vol. (ml) Fig. Chromatograms showing high-resolution SEC of six standard proteins on (A) Superose Increase / GL and (B) Superose / GL......... Vol. (ml) Fig. Chromatograms showing high-resolution SEC of six standard proteins on (A) Superose Increase / GL and (B) Superdex Increase / GL. 9-99- AA

Superose Increase / GL vs / GL column: resolution vs speed Superose Increase / GL columns are designed for high-resolution SEC at microgram to milligram scale while the smaller / GL columns are designed for rapid screening. While speed is preferable in applications such as purity checks and size homogeneity analysis, this comes at the cost of decreased resolution. As can be seen in Figure A, SEC on the / GL column of a sample consisting of six proteins gave a high-resolution separation in min. The cycle time on the / GL column on the other hand was reduced to only min, but the resolution of the separation was also significantly reduced (Fig B). Columns: Superose Increase / GL and Superose Increase / GL. Thyroglobulin (M r 9 ), mg/ml. Ferritin (M r ),. mg/ml. Aldolase (M r 8 ), mg/ml. Ovalbumin (M r ), mg/ml. Ribonuclease A (M r 7), mg/ml. Aprotinin (M r ), mg/ml Sample volumes: µl, (/ GL column) µl, (/ GL column) Buffer: PBS ( mm phosphate buffer, mm NaCl, ph 7.) Flow rates:. ml/min (/ GL column). ml/min (/ GL column) ÄKTAmicro (A) Superose Increase / GL High sensitivity for small sample volumes Superose Increase./ gives high resolution and good sensitivity for small sample volumes. A μl sample containing five standard proteins was applied both to Superose Increase./ and / GL columns. As shown in Figure, the detection signal from the run with Superose Increase./ was considerably higher compared with Superose Increase / GL. Columns: Superose Increase./ and Superose Increase / GL. Thyroglobulin (M r 9 ), mg/ml. Ferritin (M r ),. mg/ml. Aldolase (M r 8 ), mg/ml. Carbonic anhydrase (M r ), mg/ml. Aprotinin (M r ), mg/ml Sample volume: µl Buffer: PBS ( mm phosphate buffer, mm NaCl, ph 7.) Flow rates:. ml/min (./ column). ml/min (/ GL column) ÄKTAmicro (A) Superose Increase./ A 8 A 8 A 8 8..... Time (min) (B) Superose Increase / GL 8..... Vol. (ml) (B) Superose Increase / GL A 8...... Vol. (ml) Fig. A small volume ( μl) of a sample mixture containing five proteins was separated on (A) Superose Increase./ column and (B) Superose Increase / GL column. Both chromatograms show the same scale for UV detection on the y-axis..... 8.. Time (min) Fig. High-resolution SEC of six standard proteins showing relative peak resolution on (A) Superose Increase / GL compared with (B) the / GL column. 9-99- AA

Toleration of harsh cleaning procedures The long working life and high reproducibility of Superose Increase prepacked columns are the result of the optimized design, stable nature of the medium, and controlled production procedures. To demonstrate this, a test was performed to verify the chemical stability and robustness of the medium prepacked in Superose Increase / GL column. Initially, the column was tested with four standard proteins (Fig 7A) followed by a series of injections with. ml of mouse IgG b from hybridoma cells. Cleaning-in-place (CIP) with. CV of. M NaOH was performed after every injections. After injections with IgG b, a new test with standard proteins was performed. The results show very similar chromatograms for both the initial run and after injections and CIP cycles (Fig 7). Column: Superose Increase / GL. Thyroglobulin (M r 9 ), mg/ml. Aldolase (M r 8 ), mg/ml. Ovalbumin (M r ), mg/ml. Ribonuclease A (M r 7),. mg/ml Sample volume: µl Buffer: PBS ( mm phosphate buffer, mm NaCl, ph 7.) Flow rate:. ml/min ÄKTAexplorer (A) (B) A 8 A 8 8...... Vol. (ml) 8...... Vol. (ml) Fig 7. SEC of standard proteins on Superose Increase / GL (A) before and (B) after injections of IgG b including CIP cycles with. M NaOH. Determination of theoretical plates (N/m) was also performed to evaluate the column efficiency after each of the CIP runs in the experiment described above. Results show that the column efficiency remains high over time (Fig 8) and thus that the medium is chemically stable and withstands high ph. Column: Superose Increase / GL % acetone in PBS Sample volume: µl Buffer: PBS Flow rate: ml/min ÄKTAexplorer Efficiency (theoretical plates m - [N/m]) Injections Fig 8. Column efficiency measured in theoretical plates m - for injections of IgG b with cycles of CIP. Operation Choice of eluents An eluent that ensures the sample is fully soluble and, if possible, that will simplify downstream applications, should be selected. Chaotropic agents and detergents can be used to improve the solubility of membrane proteins. Since ionic interactions can occur with both acidic and basic proteins at very low salt concentrations, it is recommended to include mm to mm NaCl or to use a buffer with equivalent ionic strength to minimize these interactions. Sample volumes and flow rates When working with protein concentrations below mg/ml, SEC separation becomes less dependent on sample concentration. To achieve high resolution, the sample volume should be less than % of the total column volume. Sample volumes between.% and.% of the bed volume give the highest resolution. By decreasing flow rate, resolution can be increased. For more information, see Table. To protect the packed bed from compression, it is important to decrease flow rate when working at low temperature or with viscous solutions, see instructions for use for more details. 9-99- AA

Applications Oligomerization of a pathogenic protein involved in neurodegenerative disorders Lewy bodies are abnormal inclusions found inside nerve cells in patients with Parkinson s disease and related neurodegenerative disorders. These protein abnormalities constitute mainly aggregated forms of the protein α-synuclein. Aldehydes such as -oxo--nonenal (ONE) formed during oxidative stress are believed to be involved in the formation of Lewy bodies. Monomeric α-synuclein was incubated for h with ONE at a ratio of : (ONE: α-synuclein) and the material was separated on Superose Increase./. Figure 9A shows the peak of monomeric α-synuclein. The resulting chromatogram after incubation with ONE shows that monomeric α-synuclein has been oligomerized and no monomeric form can be detected (Fig 9B). The oligomerized material was further used for in-vitro and in-vivo studies of its neurotoxicity. Purification of a membrane protein complex for structure and molecular mechanism studies ATP synthetase complex from E. coli membrane was captured with Ni Sepharose Fast Flow and further purified on Superose Increase / GL. As seen in Figure, the resolution between aggregates (peak ) and monomer ATP synthetase protein complex was good (peak ), as well as separation from degradation products (peaks and ). In addition to small consumption of sample and buffer, the separation was achieved with low runtime, yet high resolution. The purified material was further used for structure and molecular mechanism studies. Column: Superose Increase / GL ATP synthetase complex from E. coli membrane Sample volume: µl Buffer: mm Tris-HCl, mm NaCl, % glycerol, µm MgCl,.% dodecyl maltoside, ph 8. Flow rate:. ml/min ÄKTAmicro in cold room Column: Superose Increase./ (A) Monomeric α-synuclein; (B) Monomeric α-synuclein incubated for h with the aldehyde, ONE Sample volume: µl Buffer: TBS ( mm Tris, mm NaCl, ph 7.) Flow rate: µl/min Merck Hitachi D-7 LaChrom (A). α-synuclein monomer Absorbance ATP synthetase complex Absorbance (AU)....... Vol. (ml) Peak Peak Peak Peak Fig. SEC using Superose Increase / GL of ATP synthetase complex from E. coli membrane. Peak : Aggregates; Peak : Monomer ATP synthetase complex; Peak and : Degradation products. (B)...... Time (min) Oligomerized α-synuclein Aldehyde (ONE) Acknowledgements We thank Dr. Joakim Bergström, Rudbeck Laboratory, Uppsala University for the oligomerization of α-synuclein study. Absorbance (AU)....... Time (min) Fig 9. SEC on Superose Increase./ of (A) monomeric α-synuclein and (B) monomeric α-synuclein after incubation with the aldehyde, ONE. Data courtesy of Dr. Joakim Bergström, Rudbeck Laboratory, Uppsala University. 9-99- AA

Ordering information Product Quantity Code number Superose Increase / GL 9-9-9 Superose Increase / GL 9-9-97 Superose Increase./ 9-9-98 Related products Gel Filtration LMW Calibration Kit 8-8- Gel Filtration HMW Calibration Kit 8-8- Superdex Increase / GL 8-999- Superdex Increase / GL 8-999- Superdex Increase./ 8-999- Accessories Tricorn Filter Kit 9-- Tricorn Filter Kit 9--8 Filter Tool 8-- Fingertight connector, / male 8-- Tricorn storage/shipping device 8-7- Do not store exposed to daylight Related literature Handbook: Size-exclusion chromatography, principles and methods Selection guide: Prepacked chromatography columns for ÄKTA systems Instrument management handbook: ÄKTA laboratory-scale chromatography systems 8--8 8-97-78 9-8- 9-99- AA 7

For local office contact information, visit www.gelifesciences.com/contact www.gelifesciences.com GE Healthcare UK Limited Amersham Place Little Chalfont Buckinghamshire, HP7 9NA UK GE and GE monogram are trademarks of General Electric Company. ÄKTA, Sepharose, Superdex, Superose, and Tricorn are trademarks of General Electric Company or one of its subsidiaries. Merck is a trademark of Merck, Sharpe and Dohme Corp. Hitachi is a trademark of Hitachi, Ltd. All other third-party trademarks are the property of their respective owners. IMAC Sepharose products, Ni Sepharose products and Fe Sepharose products: These products are sold under a license from Sigma-Aldrich under patent number EP 77 (Metal chelating compositions) and equivalent patents and patent applications in other countries. General Electric Company All rights reserved. First published Oct. All goods and services are sold subject to the terms and conditions of sale of the company within GE Healthcare which supplies them. A copy of these terms and conditions is available on request. Contact your local GE Healthcare representative for the most current information. GE Healthcare Bio-Sciences AB Björkgatan 7 8 Uppsala Sweden GE Healthcare Europe, GmbH Munzinger Strasse D-79 Freiburg Germany GE Healthcare Bio-Sciences Corp. 8 Centennial Avenue, P.O. Box 7 Piscataway, NJ 88-7 USA GE Healthcare Japan Corporation Sanken Bldg., --, Hyakunincho Shinjuku-ku, Tokyo 9-7 Japan 9-99- AA /